// App-Quantinova.ai

O16 : A study examining the reliability of digital ulcer definitions as proposed by the UK Scleroderma Study Group: challenges and insights for future clinical trial design

Researchers

Presenter

  • Michael Hughes

Principal Investigators

  • Monica Bhushan

  • Kuntal Chakravarty

  • Christopher P Denton

  • Shirish Dubey

  • Serena Guiducci

  • Lindsay Muir

  • Voon Ong

  • Louise Parker

  • John Pauling

  • Athiveeraramapandian Prabu

  • Janet Ravenscroft

  • Christopher Roberts

  • Christine Rogers

  • Andrew Tracey

  • Ariane L Herrick

Medical Centers

  • Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK

  • Department of Dermatology, Blackpool Teaching Hospitals NHS Foundation Trust, Lytham St Annes, UNITED KINGDOM

  • Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital, London, UK

  • Department of Rheumatology, University Hosptal Coventry and Warwickshire NHS Trust, Coventry, UNITED KINGDOM

  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

  • Department of Rheumatology, Salisbury NHS Foundation Trust, Salisbury, UNITED KINGDOM

  • Department of Pharmacy and Pharmacology, University of Bath, Bath, UNITED KINGDOM

  • Rheumatology Department, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom

  • Member of Working Group, contact via Professor Herrick, The University of Manchester, Manchester, UNITED KINGDOM

  • Centre for biostatistics, The University of Manchester, Manchester, UK

  • The University of Manchester, The University of Manchester, Manchester, UNITED KINGDOM

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A